β-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats

Anesthesia and Analgesia

Volumn 103, Issue 3, 2006, Pages 658-663

  Goyagi, Toru ^a   Kimura, Tetsu ^a   Nishikawa, Toshiaki ^a   Tobe, Yoshitsugu ^a   Masaki, Yoko ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; ESMOLOL; LANDIOLOL; PROPRANOLOL; CARBAZOLE DERIVATIVE; DRUG DERIVATIVE; HALOTHANE; INHALATION ANESTHETIC AGENT; MORPHOLINE DERIVATIVE; PROPANOLAMINE DERIVATIVE; TETRAZOLIUM; TRIPHENYLTETRAZOLIUM; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CISTERNA MAGNA; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG EFFICACY; EVALUATION; HISTOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; RAT STRAIN; REPERFUSION; SCORING SYSTEM; SURVIVAL TIME; ANESTHESIA; ANIMAL; BRAIN; HEART INFARCTION; SPRAGUE DAWLEY RAT; TRANSIENT ISCHEMIC ATTACK;

ADRENERGIC BETA-ANTAGONISTS; ANESTHESIA; ANESTHETICS, INHALATION; ANIMALS; BRAIN; CARBAZOLES; HALOTHANE; ISCHEMIC ATTACK, TRANSIENT; MALE; MORPHOLINES; MYOCARDIAL INFARCTION; PROPANOLAMINES; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLIUM SALTS; UREA;

EID: 33749078021     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000228859.95126.69     Document Type: Article

References (43)

1. Pinelli A, Trivulzio S, Tomasoni L, et al. Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure. Eur J Pharm Sci 2004;23:277-85.
2. Solez K, Freshwater MF, Su CT. The effect of propranolol on post-ischemic acute renal failure in the rat. Transplantation 1977;24:148-51.
3. Stowe N, Emma J, Magnusson M, et al. Protective effect of propranolol in the treatment of ischemically damaged canine kidneys prior to transplantation. Surgery 1978;84:265-70.
4. Yao H, Sadoshima S, Shiokawa O, et al. Renal blood flow in acute cerebral ischemia in spontaneously hypertensive rats: effects of alpha- and beta-adrenergic blockade. Stroke 1987;18:629-33.
5. Kloner RA, Rezkalla SH. Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol 2004;44:276-86.
6. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003;97:623-33.
7. Standefer M, Little JR. Improved neurological outcome in experimental focal cerebral ischemia treated with propranolol. Neurosurgery 1986;18:136-40.
8. Latchaw JP, Little JR, Slugg RM, et al. Treatment of acute focal cerebral ischemia and recirculation with d-propranolol. Neurosurgery 1985;16:18-22.
9. Capraro JA, Reedy DP, Latchaw JP, et al. Treatment of acute focal cerebral ischemia with propranolol. Stroke 1984;15:486-91.
10. Little JR, Latchaw JP Jr, Slugg RM, et al. Treatment of acute focal cerebral ischemia with propranolol. Stroke 1982;13:302-7.
11. Rabasseda X. Carvedilol: an effective antihypertensive drug with antiischemic/antioxidant cardioprotective properties. Drugs Today 1998;34:905-26.
12. Savitz SI, Erhardt JA, Anthony JV, et al. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab 2000;20:1197-204.
13. Oliveira PJ, Goncalves L, Monteiro P, et al. Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria? Curr Vasc Pharmacol 2005;3:147-58.
14. Semkova I, Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res Rev 1999;30:176-88.
15. Culmsee C, Junker V, Kremers W, et al. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke 2004;35:1197-202.
16. Junker V, Becker A, Huhne R, et al. Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol 2002;446:25-36.
17. Ordway GA, Gambarana C, Frazer A. Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol. J Pharmacol Exp Ther 1988;247:379-89.
18. Semkova I, Schilling M, Henrich-Noack P, et al. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res 1996;717:44-54.
19. 14C] iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981;1:61-8.
20. Iliodromitis EK, Tasouli A, Andreadou I, et al. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo. Eur J Pharmacol 2004;499:163-9.
21. 1- adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other β-adrenoceptor antagonists. Br J Pharmacol 2000;130:759-66.
22. Goyagi T, Goto S, Bhardwaj A, et al. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. Stroke 2001;32:1613-20.
23. Goyagi T, Toung TJ, Kirsch JR, et al. Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats. Stroke 2003;34:1533-8.
24. Maier CM, Sun GH, Kunis D, et al. Delayed induction and long-term effects of mild hypothermia in a focal model of transient cerebral ischemia. J Neurosurg 2001;94:90-6.
25. Baker AJ, Zornow MH, Grafe MR, et al. Hypothermia prevents ischemia-induced increases in hippocampal glycine concentrations in rabbits. Stroke 1991;22:666-73.
26. Mackenzie ET, McCulloch J, Harper AM. Influence of endogenous norepinephrine on cerebral blood flow and metabolism. Am J Physiol 1976;231:483-8.
27. Weksler BB, Gillick M, Pink J. Effects of propranolol on platelet function. Blood 1977;49:185-96.
28. Braunwald E. Mechanism of action of calcium channel blocking agents. N Engl J Med 1982;307:1618-27.
29. Lindemann JP, Bailev JC, Watanabe AM. Potential biochemical mechanisms for regulation of the slow inward current: Theoretical basis for drug action. Am Heart J 1982;103:746-56.
30. 2 in human platelets. Mol Pharmacol 1978;16:171-80.
31. Follesa P, Mocchetti I. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by β-adrenergic receptor activation and adrenal steroids in rat central nervous system. Mol Pharmacol 1992;43:132-8.
32. Hayes VY, Isackson PJ, Fabrazzo M, et al. Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: contrasting anatomical and cellular localization. Exp Neurol 1995;132:33-41.
33. Hartikka J, Hefti F. Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymes. J Neurosci 1988;8:2967-85.
34. Whittemore SR, Seiger A. The expression, localization and functional significance of β-nerve growth factor in the central nervous system. Brain Res Rev 1987;12:439-46.
35. Hefti F, Dravid A, Hartikka J. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res 1984;293:305-11.
36. Buchan AM, Williams L, Bruederlin B. Nerve growth factor: pretreatment ameliorates ischemic hippocampal neuronal injury. Stroke 1990;21:177-182.
37. Shigeno T, Mima T, Takaura K, et al. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J Neurosci 1991;11:2914-9.
38. Pechan PA, Yoshida T, Panahian N, et al. Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat. NeuroReport 1995;6:669-72.
39. 2- adrenergic receptors in rat brain. Proc Natl Acad Sci U S A 1984;81:1585-9.
40. Shao Y, Sutin J. Noradrenergic facilitation of motor neurons: localization of adrenergic receptors in neurons and nonneuronal cells in the trigeminal motor nucleus. Exp Neurol 1991;114:216-27.
41. Gasche Y, Fujimura M, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 1999;19:1020-8.
42. Quon CY, Stampfli HF. Biochemical properties of blood esmolol esterase. Drug Metab Dispos 1985;13:420-4.
43. Quon CY, Mai K, Patil G, Stampfli HF. Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Drug Metab Dispos 1988;16:425-8.